A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/19 (2006.01) A61K 31/4015 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2740610
This invention relates to treating age-related cognitive im-pairment. This invention in particular relates to the use of inhibitors of synaptic vesicle protein 2A (SV2A), such as levetiracetam, seletracetam, and brivaracetam, in improving cog-nitive function in subjects that exhib-it age-related cognitive impairment or are at risk thereof, including, with-out limitation, subjects having or at risk for Mild Cognitive Impairment (MCI), Age-related Cognitive De-cline (ARCD) or Age-Associated Memory Impairment (AAMI).
L'invention porte sur le traitement d'un trouble cognitif lié à l'âge. Cette invention porte en particulier sur l'utilisation d'inhibiteurs de protéines de vésicule synaptique 2A (SV2A), tels que le lévétiracetam, le seletracetam et le brivaracetam, dans l'amélioration d'une fonction cognitive chez des sujets qui présentent un trouble cognitif lié à l'âge ou qui risquent celui-ci, incluant, mais sans limitation, des sujets présentant ou risquant de présenter un trouble cognitif léger (MCI), un déclin cognitif lié à l'âge (ARCD) ou un trouble de la mémoire associé à l'âge (AAMI).
Gallagher Michela
Haberman Rebecca
Koh Ming Teng
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
The Johns Hopkins University
LandOfFree
Methods and compositions for improving cognitive function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for improving cognitive function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for improving cognitive function will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1482010